Last Updated 20 May 2022.
4 Vaccines Approved for Use in Switzerland
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 37 countries
15 trials in 12 countries
Approval Source: seekingalpha.com
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
63 trials in 22 countries
Approval Source: swissinfo.ch
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
80 trials in 26 countries
Approval Source: bag.admin.ch
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
3 Vaccines in Clinical Trials in Switzerland
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
63 trials in 22 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
80 trials in 26 countries
-
Emergex Vaccines Holding Ltd
PepGNP-SARSCoV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country